Header Image for Indocin vs Celebrex

Indocin vs Celebrex

Listen to the article instead of reading through it.
0:00

Overview

Indocin Information

Celebrex Information

Comparative Analysis

Indocin Prescription Information

Celebrex Prescription Information

Indocin Side Effects

Celebrex Side Effects

Safety Information

Cost Analysis

Market Analysis

Summary

Introduction

For patients experiencing pain, inflammation or stiffness from conditions such as osteoarthritis, rheumatoid arthritis or ankylosing spondylitis, certain drugs that inhibit the production of inflammatory chemicals in the body can help in managing symptoms. Indocin and Celebrex are two such drugs often prescribed for these conditions. Both belong to a class of medications known as non-steroidal anti-inflammatory drugs (NSAIDs), but they work slightly differently within this category. Indocin is a traditional NSAID which not only reduces inflammation but also inhibits platelet aggregation and might increase risk of gastrointestinal bleeding. Celebrex on the other hand belongs to a subclass called COX-2 inhibitors, primarily affecting cyclooxygenase-2 enzymes responsible for inflammation and pain with lesser effects on platelets thus potentially offering a safer profile for gastric side effects.

Indocin vs Celebrex Side By Side

AttributeIndocinCelebrex
Brand NameIndocinCelebrex
ContraindicationsShould not be taken if recently undergone coronary artery bypass graft surgery. May interfere with certain blood pressure medications.Should not be taken if recently undergone coronary artery bypass graft surgery or planning to have one soon. Increased risk of heart attack and stroke.
CostFor brand-name, around $260 for 60 capsules of 25 mg. For generic indomethacin, costs range from about $.35-$1 per day.For brand-name, about $240 for 30 capsules of 200 mg. For generic celecoxib, costs range from about $.75-$2.50 per day.
Generic NameIndomethacinCelecoxib
Most Serious Side EffectSevere skin reactions, liver problems, kidney problems, low blood cell counts, heart attack signs.Allergic reactions, serious heart issues, signs of stomach bleeding, liver problems, kidney problems.
Severe Drug InteractionsCan interfere with certain blood pressure medications.Increased risk of heart attack and stroke, especially if used for an extended period.
Typical Dose25-200 mg/day in divided doses, with a common dose being 50 mg three times per day.100–200 mg/day, up to 400 mg/day if needed, divided into two doses.

What is Indocin?

Indomethacin (the generic name for Indocin) is a nonsteroidal anti-inflammatory drug (NSAID) that was first approved by the FDA in 1965. It works by reducing hormones that cause inflammation and pain in the body, and is commonly used to relieve moderate to severe osteoarthritis, rheumatoid arthritis, gouty arthritis or ankylosing spondylitis. Celecoxib (the generic name for Celebrex), another NSAID, was first approved by the FDA much later in 1999. Like Indomethacin, it also relieves pain and inflammation but does so selectively blocking an enzyme called COX-2 which results in lower chances of stomach ulcers and gastrointestinal bleeding - common side effects associated with many other NSAIDs including Indocin. While both drugs are effective at managing pain and inflammation, they have differences when it comes to potency as well as risk of certain side effects making patient's individual health history important when choosing between them.

What conditions is Indocin approved to treat?

Indocin and Celebrex are both approved for the treatment of various forms of pain and inflammation, such as:

  • Rheumatoid arthritis
  • Osteoarthritis
  • Acute gouty arthritis (specifically for Indocin)
  • Ankylosing spondylitis
  • Pain from various conditions like menstrual cramps or injuries.

It's worth noting that Celebrex is also used to reduce the number of colon and rectum polyps in patients with familial adenomatous polyposis.

How does Indocin help with these illnesses?

Indocin, also known as indomethacin, manages inflammation and pain by reducing the levels of prostaglandins in the body. Prostaglandins are chemicals that promote inflammation, pain, and fever. Indocin does this by inhibiting an enzyme called cyclooxygenase (COX), which is involved in producing these prostaglandins. This means that higher levels of indomethacin can maintain lower levels of prostaglandins for longer periods of time.

Prostaglandins are crucial messengers in many bodily functions including maintaining the protective lining in your stomach and regulating blood flow to the kidneys. However, when produced excessively due to injury or illness they lead to inflammation, pain or fevers. So while increasing indomethacin may decrease certain symptoms like swelling or discomfort it could potentially have side effects like stomach ulcers if not managed properly.

On the other hand Celebrex (celecoxib) has a similar mode of action but is more selective - it mainly inhibits COX-2 which is primarily responsible for generating prostaglandins that mediate pain and inflammation whereas COX-1 maintains gastric mucosa among other physiological actions; hence Celebrex tends to cause less gastrointestinal issues than non-selective NSAIDs such as Indocin.

What is Celebrex?

Celebrex, the trade name for celecoxib, is a selective COX-2 inhibitor within the nonsteroidal anti-inflammatory drug (NSAID) class. It acts by reducing the production of prostaglandins—substances in the body that cause inflammation and pain. In contrast to Indocin (indomethacin), which inhibits both COX-1 and COX-2 enzymes, Celebrex specifically targets COX-2 enzymes while sparing COX-1. This specificity makes it less likely to produce certain gastrointestinal side effects like stomach ulcers and bleeding commonly associated with NSAIDs such as indomethacin.

First approved by FDA in 1998, Celebrex can be beneficial for patients suffering from conditions like osteoarthritis, rheumatoid arthritis or acute pain who require long-term pain management but are at risk of developing gastrointestinal complications from other NSAIDs.

What conditions is Celebrex approved to treat?

Celebrex is an FDA-approved medication for the management of:

  • Osteoarthritis (OA), a degenerative joint disease
  • Rheumatoid Arthritis (RA), an autoimmune disease causing inflammation in the joints
  • Ankylosing spondylitis, a type of arthritis affecting the spine
  • Acute pain and menstrual cramps

How does Celebrex help with these illnesses?

Celecoxib, marketed as Celebrex, is an anti-inflammatory medication that works by inhibiting the enzyme cyclooxygenase-2 (COX-2), which plays a significant role in pain and inflammation responses in the body. This selective inhibition allows it to target inflammation with less impact on other physiological processes compared to non-selective NSAIDs like Indocin (Indomethacin). While both drugs can effectively manage pain and reduce inflammation, Celebrex's selective action means it may cause fewer gastrointestinal side effects than non-selective NSAIDs. It should be noted, however, that individual response can vary greatly; some patients may find greater relief from one drug over another or may tolerate one better than the other based on their unique health profile.

How effective are both Indocin and Celebrex?

Both Indomethacin (Indocin) and Celecoxib (Celebrex) have established histories of success in treating patients with various forms of arthritis, including rheumatoid arthritis and osteoarthritis. They were approved by the FDA several decades apart; Indocin was first made available in 1965 while Celebrex entered the market in 1999. As both drugs are nonsteroidal anti-inflammatory drugs (NSAIDs), they work by reducing substances in the body that cause inflammation.

Comparative studies between Indocin and Celebrex show similar efficacy for pain management related to arthritic conditions, but there appear to be differences when it comes to side effects profiles. A meta-analysis published in 2012 pointed out that selective COX-2 inhibitors like Celebrex may have a lower risk of causing stomach ulcers compared with traditional NSAIDs such as Indocin.

Indomethacin is known for its effectiveness against moderate to severe acute or chronic pain associated with inflammatory conditions. It has also been used off-label for other painful conditions such as gout attacks, although this use has been replaced more recently by newer medications due to concerns about gastrointestinal side effects and risks.

On the other hand, according to a review from 2008, celecoxib seems particularly effective at managing symptoms associated with osteoarthritis and rheumatoid arthritis without some of the common side-effects seen with traditional NSAIDs like indomethacin – specifically gastric irritation leading potentially ulceration or bleeding. However, celecoxib was linked to increased cardiovascular risks which led regulatory authorities around the world issuing warnings regarding its usage among patients who previously had heart disease or stroke.

abstract image of a researcher studying a bottle of drug.

Find Top Clinical Trials

Choose from over 30,000 active clinical trials.

At what dose is Indocin typically prescribed?

Oral dosages of Indocin typically range from 25-200 mg/day in divided doses, but studies have indicated that a dose of 50 mg three times per day is often sufficient for treating moderate to severe rheumatoid arthritis, osteoarthritis, or ankylosing spondylitis. Dosage can be increased after several weeks if there's no adequate response. However, the daily dosage should not exceed 200mg. On the other hand, Celebrex is usually administered at a dose of 100-200 mg once or twice per day for similar conditions. Children and adolescents' dosage should be determined by their doctor based on condition severity and patient tolerance. The maximum dosage for Celebrex that should not be exceeded in any case is 400 mg/day.

At what dose is Celebrex typically prescribed?

Celebrex treatment typically starts at a dosage of 100–200 mg/day for managing various conditions including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and menstrual pain. The dose can then be increased to up to 400 mg/day if needed, divided into two doses spaced about 12 hours apart. For acute pain or menstrual cramps, the maximum dose is 400 mg on the first day (given as a single dose or split into two), followed by a maintenance dosage of 200 mg twice daily as necessary. If there is no response to Celebrex treatment at these dosages after several weeks, you should consult your healthcare provider for possible adjustments in your medication regimen or alternative options.

What are the most common side effects for Indocin?

Common side effects of Indocin and Celebrex can include:

  • Stomach pain, indigestion
  • Diarrhea or constipation
  • Headache
  • Dizziness
  • Fatigue, sleepiness/drowsiness
  • Nervousness
  • Ringing in your ears (tinnitus)
  • Increased blood pressure
  • Excessive sweating -Dry mouth -Skin rash or itching -Stuffy nose, sinusitis or other cold symptoms

It's important to note that while these are common side effects, they don't occur in everyone taking the medication. Always consult with a healthcare provider if you experience any unusual or bothersome side effects when taking either of these medications.

abstract image of a patient experiencing side effect

Are there any potential serious side effects for Indocin?

Serious side effects of Indocin are not common, but can occur. If you experience any of the following symptoms while taking Indocin, seek immediate medical attention:

  • Signs of an allergic reaction: hives; difficulty breathing; swelling in your face or throat
  • Severe skin reactions: fever, sore throat, burning eyes, skin pain and a red or purple skin rash that spreads and causes blistering and peeling
  • Liver problems: nausea or vomiting that doesn't go away, loss of appetite for several days or longer, yellowing of the eyes or skin (jaundice), dark urine
  • Kidney problems: change in how often you urinate; unexplained weight gain; swelling in your feet/legs/hands
  • Low blood cell counts - pale skin with feeling tiredness/fatigue/shortness breath/light-headed/dizziness
  • Heart attack signs: chest pain spreading to your jaw/left arm/sudden numbness on one side body/speech changes.

Like any medicine, Celebrex has potential risks as well. Some serious side effects include:

  • Allergic reactions like hives/swelling in your face/throat/difficulty breathing
  • Serious heart issues such as chest discomfort/pain/spreading to jaw/arm/feeling short breath/lightheadedness/or fainting.

Please note that this is not a complete list of possible side effects. If you notice other effects not listed here contact your doctor immediately.

What are the most common side effects for Celebrex?

Celebrex, similar to other non-steroidal anti-inflammatory drugs (NSAIDs), can cause a variety of side effects. Some of these may include:

  • Indigestion, stomach pain and ulcers
  • Diarrhea or constipation
  • Headaches and dizziness
  • High blood pressure
  • Swelling in the hands or feet (fluid retention)
  • Skin rash
  • Difficulty breathing or swallowing due to allergic reactions It's worth noting that while Celebrex is designed to reduce inflammation and pain, it doesn't treat the underlying cause of these symptoms. Always consult your healthcare provider for advice tailored to your specific circumstances.

Are there any potential serious side effects for Celebrex?

While Celebrex is generally considered safe for most patients, it does carry a risk of certain side effects. These can range from mild to severe and include:

  • Allergic reactions such as hives, difficulty breathing, swelling in your face or throat;
  • Chest pain spreading to your jaw or shoulder, sudden numbness or weakness on one side of the body, slurred speech, shortness of breath;
  • Signs of stomach bleeding - bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds;
  • Liver problems - nausea, upper stomach pain, itching, tired feeling, flu-like symptoms; loss of appetite; dark urine, clay-colored stools; jaundice (yellowing of the skin or eyes);
  • Kidney problems - little or no urinating; painful or difficult urination; swelling in your feet or ankles.

If you experience any signs and symptoms related to these severe conditions while taking Celebrex stop using this medication immediately and seek emergency medical attention.

Contraindications for Indocin and Celebrex?

Indocin and Celebrex, like all NSAIDs, can potentially cause serious side effects. If you notice any signs of stomach bleeding (such as black or bloody stools) or kidney problems (such as changes in the amount of urine), seek immediate medical attention.

Neither Indocin nor Celebrex should be taken if you have recently undergone coronary artery bypass graft surgery or are planning to have one soon due to increased risk of heart attack and stroke. Always inform your physician about any medications you are taking; some drugs might interact negatively with Indocin and Celebrex.

These medicines may also lead to a higher chance of developing life-threatening heart or circulation conditions including heart attack or stroke, especially if they’re used for an extended period. Elderly patients and those with existing cardiovascular diseases should exercise caution while using these drugs.

Indomethacin (the active ingredient in Indocin) is known to interfere with certain blood pressure medications so always keep your doctor informed about any concurrent treatments.

How much do Indocin and Celebrex cost?

For the brand-name versions of these drugs:

  • The price for 60 capsules of Indocin (25 mg) averages around $260, which works out to approximately $4.33–$8.67/day, depending on your dose.
  • The price for 30 capsules of Celebrex (200 mg) is about $240, working out to roughly $8/day.

Thus, if you are in the higher dosage range for Indocin (i.e., 150 mg/day or higher), then brand-name Celebrex might be less expensive on a per-day treatment basis. Please note that cost should not be a primary consideration in determining which of these drugs is right for you.

As it pertains to the generic versions of Indocin (indomethacin) and Celebrex (celecoxib), costs are significantly lower:

  • Indomethacin can be purchased in packs from as low as 20 up to 120 capsules at doses between 25mg and 50mg with approximate costs ranging from about $.35-$1 per day based on your daily dosage.
  • Similarly, celecoxib can come in quantities spanning from below thirty pills to upwards of one hundred pills with an average cost between $.75-$2.50 per day again dependent upon whether you're taking anywhere between once-daily dosages all the way up towards four times daily dosages.

These prices fluctuate based on where they're purchased so make sure shop wisely when considering any medication options!

Popularity of Indocin and Celebrex

Indomethacin, available in generic form and under the brand name Indocin, was prescribed to approximately 2 million people in the US in 2020. As a nonselective nonsteroidal anti-inflammatory drug (NSAID), indomethacin is used to treat moderate to severe pain from various conditions such as arthritis, gout and inflammation of the shoulders. It accounted for about 1% of all NSAID prescriptions.

Celecoxib, including brand versions such as Celebrex, was prescribed to around 6 million people in the USA during that same year. In the US market for prescription NSAIDs specifically indicated for osteoarthritis or rheumatoid arthritis, celecoxib holds a significant share - with nearly one-third of all prescriptions. This can be attributed to its selective inhibition of COX-2 enzymes which tends towards reduced gastrointestinal side effects compared with non-selective NSAIDs like indomethacin. The use of celecoxib has been generally increasing over recent years due to this advantage.

Conclusion

Indocin (indomethacin) and Celebrex (celecoxib) are both nonsteroidal anti-inflammatory drugs (NSAIDs) used to relieve pain, inflammation, and stiffness caused by conditions such as arthritis. They have long histories of use in managing these symptoms but operate through different mechanisms. Indocin works by reducing levels of prostaglandins, chemicals that cells release in response to illness or injury. Celebrex specifically inhibits the COX-2 enzyme, which is primarily responsible for producing prostaglandins.

In some instances, these medications may be combined under careful medical supervision due to their potential for harmful interactions. While both drugs are available in generic form offering cost-effectiveness particularly to those paying out-of-pocket, they require close monitoring when first started as effects may not be immediate.

The side effect profiles for both indomethacin and celecoxib are similar with gastrointestinal upset being common among users of NSAIDs; however, Celebrex has a lower risk of stomach ulcers than Indocin because it selectively targets COX-2 enzymes without affecting the protective COX-1 enzymes found in the gut lining. Despite this generally well-tolerated nature between them patients should consult a healthcare professional immediately if experiencing any adverse reactions.

Refrences

  • Nalamachu, S., & Wortmann, R. (2014, July). Role of Indomethacin in Acute Pain and Inflammation Management: A Review of the Literature. Postgraduate Medicine. Informa UK Limited.http://doi.org/10.3810/pgm.2014.07.2787
  • Seibert, K., Masferrer, J., Zhang, Y., Gregory, S., Olson, G., Häuser, S., … Isakson, P. (1995). Mediation of Inflammation by Cyclooxygenase-2. Novel Molecular Approaches to Anti-Inflammatory Therapy. Birkhäuser Basel.http://doi.org/10.1007/978-3-0348-7276-8_5
  • Frampton, J. E., & Keating, G. M. (2007). Celecoxib. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200767160-00008
  • Andri, L., & Falagiani, P. (2007, July). Safety of Celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance. Allergologia et Immunopathologia. Codon Publications.http://doi.org/10.1157/13108222
  • Akarca, U. (2005, May 1). Gastrointestinal Effects of Selective and Non-Selective Non-Steroidal Anti- Inflammatory Drugs. Current Pharmaceutical Design. Bentham Science Publishers Ltd.http://doi.org/10.2174/1381612053764904